(Q41643038)

6 October 2017

1 reference

title

Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation (English)

1 reference

6 October 2017

1 reference

1 reference

Vandenbroucke JP

1

1 reference

6 October 2017

Helmerhorst FM

series ordinal

2

1 reference

6 October 2017

Bloemenkamp KW

series ordinal

3

1 reference

6 October 2017

Rosendaal FR

series ordinal

4

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

American Journal of Obstetrics and Gynecology

6 October 2017

published in

1 reference

6 October 2017

volume

177

1 reference

6 October 2017

issue

4

1 reference

6 October 2017

page(s)

887-891

1 reference

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Oral contraceptives and venous thromboembolism: an epidemiological review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Thrombosis, phlebitis, and varicose veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Could preferential prescribing and referral behaviour of physicians explain the elevated thrombosis risk found to be associated with third generation oral contraceptives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Oral contraceptives and thrombotic diseases: impact of new epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Thrombosis with low-estrogen oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Postoperative Thromboembolism and the Use of Oral Contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Oral contraceptive switching patterns in the United Kingdom: an important potential confounding variable in studies of venous thromboembolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Mutation in blood coagulation factor V associated with resistance to activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970289-8

10.1016/S0002-9378(97)70289-8

7 January 2021

Identifiers

DOI

1 reference

6 October 2017

1 reference